Strategic partnerships Epredia is actively expanding through collaborations with pathology providers and labs (NPIC, Leeds Teaching Hospitals NHS Trust, Lab Improvements) to deploy advanced diagnostic technologies, presenting opportunities to position complementary products and services to large downstream customers.

Digital pathology upgrades Recent recognition for digital pathology solutions (Epredia E1000 Dx) and partnerships aimed at automated archiving (BlockTracker, SlideTracker) indicate a growing market shift toward integrated digital workflows, suggesting upsell potential for data management, analytics, and automation offerings.

Global cancer diagnostics With a broad global footprint and a high usage rate of its products in cancer diagnostics, Epredia presents chances to cross-sell orders of bundled instruments, consumables, and service agreements to maximize uptime and precision across international sites.

Innovation and awards Industry recognition as Best New Diagnostic Technology Solution signals strong market validation; a compelling basis to approach prospective customers with case studies, ROI analytics, and expanded product lines aligned to digital transformation and precision pathology.

PHC ecosystem As a subsidiary of PHC Holdings, Epredia can leverage corporate relationships, funding, and co-selling opportunities within the PHC portfolio to accelerate access to large healthcare systems and multi-site deployments.